<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Urology Product Guide &#187; mesalamine</title>
	<atom:link href="http://www.urologyproductguide.com/blog/tag/mesalamine/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.urologyproductguide.com/blog</link>
	<description>A comprehensive guide to urology products for medical professionals</description>
	<lastBuildDate>Fri, 23 Jul 2010 08:07:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>P&amp;G launches Asacol HD</title>
		<link>http://www.urologyproductguide.com/blog/2009/07/10/pg-launches-asacol-hd/</link>
		<comments>http://www.urologyproductguide.com/blog/2009/07/10/pg-launches-asacol-hd/#comments</comments>
		<pubDate>Fri, 10 Jul 2009 05:02:04 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Asacol HD]]></category>
		<category><![CDATA[inflammatory bowel disease]]></category>
		<category><![CDATA[mesalamine]]></category>
		<category><![CDATA[P&G]]></category>
		<category><![CDATA[Procter & Gamble]]></category>
		<category><![CDATA[UC]]></category>
		<category><![CDATA[ulcerative colitis]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/2009/07/10/pg-launches-asacol-hd/</guid>
		<description><![CDATA[Procter &#38; Gamble Pharmaceuticals has launched Asacol HD (mesalamine) delayed-release tablets for the treatment of moderately active ulcerative colitis (UC), a form of inflammatory bowel disease. UC involves inflammation of the lining of the colon and rectum and is typically characterized by flares followed by periods of remission. Asacol HD 4.8 g/day 800 mg tablet [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.urologyproductguide.com/blog/wp-content/uploads/2009/07/asacol.png" hspace="5" height="81" width="200" vspace="5" align="right" />Procter &amp; Gamble Pharmaceuticals has launched Asacol HD (mesalamine) delayed-release tablets for the treatment of moderately active ulcerative colitis (UC), a form of inflammatory bowel disease. UC involves inflammation of the lining of the colon and rectum and is typically characterized by flares followed by periods of remission. Asacol HD 4.8 g/day 800 mg tablet was approved by the US FDA.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2009/07/10/pg-launches-asacol-hd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
